Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap as of August 2026

World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.

Metatag Title
World Top Healthcare Companies in 2026
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.
  1. GE Healthcare Technologies

    World Rank (Aug-2026)
    792
    Market Cap (Aug-2026)
    33.285 Billion USD
    World Rank (Jan-05-2024)
    523
    Market Cap (Jan-05-2024)
    34.858 Billion USD
    World Rank (Jul-30-2023)
    528
    Market Cap (Jul-30-2023)
    35.418 Billion USD
    World Rank (Dec-25-2022)
    640
    Market Cap (Dec-25-2022)
    26.527 Billion USD
    Annual Revenue in USD
    18,341 Million USD
    Annual Operating Income in USD
    2,522 Million USD
    Annual Net Income in USD
    1,916 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Medical Technology company related to healthcare diagnostics and digital solutions. Headquarters is in USA.

  2. Celltrion

    World Rank (Aug-2026)
    794
    Market Cap (Aug-2026)
    33.137 Billion USD
    World Rank (Jan-05-2024)
    509
    Market Cap (Jan-05-2024)
    35.824 Billion USD
    World Rank (Jul-30-2023)
    1,134
    Market Cap (Jul-30-2023)
    16.020 Billion USD
    World Rank (Dec-25-2022)
    883
    Market Cap (Dec-25-2022)
    18.618 Billion USD
    World Rank (Jan-07-2022)
    985
    Market Cap (Jan-07-2022)
    21.21 Billion USD
    Annual Revenue in USD
    1,793 Million USD
    Annual Operating Income in USD
    508 Million USD
    Annual Net Income in USD
    422 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Celltrion is a Biopharmaceutical company. The headquarters is in South Korea.

    Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.

  3. Novozymes A/S

    World Rank (Aug-2026)
    801
    Market Cap (Aug-2026)
    32.823 Billion USD
    World Rank (Jan-05-2024)
    1,197
    Market Cap (Jan-05-2024)
    14.692 Billion USD
    World Rank (Jul-30-2023)
    1,283
    Market Cap (Jul-30-2023)
    13.844 Billion USD
    World Rank (Dec-25-2022)
    1,165
    Market Cap (Dec-25-2022)
    13.689 Billion USD
    World Rank (Jan-07-2022)
    959
    Market Cap (Jan-07-2022)
    21.91 Billion USD
    Annual Revenue in USD
    2,595 Million USD
    Annual Operating Income in USD
    655 Million USD
    Annual Net Income in USD
    543 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Novozymes is a Biotechnology and Pharmaceutical company with headquarters is in Denmark.

    Facts About Company

    For year ending Dec-2022, Novozymes annual revenue was 17,553 million DKK and EBITDA was 6,046 million DKK and net profit was 3,686 million DKK.

    As on December-2022, Novozymes had 6,700 employees.

  4. ResMed

    World Rank (Aug-2026)
    804
    Market Cap (Aug-2026)
    32.559 Billion USD
    World Rank (Jan-05-2024)
    751
    Market Cap (Jan-05-2024)
    24.650 Billion USD
    World Rank (Jul-30-2023)
    575
    Market Cap (Jul-30-2023)
    32.791 Billion USD
    World Rank (Dec-25-2022)
    550
    Market Cap (Dec-25-2022)
    30.515 Billion USD
    World Rank (Jan-07-2022)
    600
    Market Cap (Jan-07-2022)
    34.57 Billion USD
    Annual Revenue in USD
    4,222 Million USD
    Annual Operating Income in USD
    1,151 Million USD
    Annual Net Income in USD
    897 Million USD
    Annual Results for Period Ending
    Jun-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    RESMED is Medical equipment manufacturing company related to breathing disorders with headquarters is in California, USA.

    As on 2022, RESMED has 8,160 employees.

    RESMED annual revenue generated for period ending Jun-2022 was 3,578 million USD.

    RESMED annual net income generated for period ending Jun-2022 was 779 million USD.

  5. Horizon Therapeutics Public Company

    World Rank (Aug-2026)
    819
    World Rank (Jan-05-2024)
    819
    World Rank (Jul-30-2023)
    819
    Market Cap (Jul-30-2023)
    22.879 Billion USD
    World Rank (Dec-25-2022)
    660
    Market Cap (Dec-25-2022)
    25.647 Billion USD
    World Rank (Jan-07-2022)
    940
    Market Cap (Jan-07-2022)
    22.27 Billion USD
    Annual Revenue in USD
    3,629 Million USD
    Annual Operating Income in USD
    729 Million USD
    Annual Net Income in USD
    521 Million USD
    Annual Results for Period Ending
    Jun-2022 ending year
    Headquarters Country
    Company Profile

    Horizon Therapeutics is a Pharmaceutical company with headquarters is in Ireland.

    Amgen acquired Horizon Therapeutics for 27.8 billion USD in Oct-2023.

  6. Daiichi Sankyo Company

    World Rank (Aug-2026)
    835
    Market Cap (Aug-2026)
    31.322 Billion USD
    World Rank (Jan-05-2024)
    329
    Market Cap (Jan-05-2024)
    53.253 Billion USD
    World Rank (Jul-30-2023)
    306
    Market Cap (Jul-30-2023)
    55.893 Billion USD
    World Rank (Dec-25-2022)
    231
    Market Cap (Dec-25-2022)
    61.852 Billion USD
    World Rank (Jan-07-2022)
    499
    Market Cap (Jan-07-2022)
    40.77 Billion USD
    Annual Revenue in USD
    9,057 Million USD
    Annual Operating Income in USD
    854 Million USD
    Annual Net Income in USD
    773 Million USD
    Annual Results for Period Ending
    Mar-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    DAIICHI SANKYO COMPANY is Pharmaceutical and Medical equipment manufacturing company with headquarters is in Tokyo, Japan.

  7. Biogen

    World Rank (Aug-2026)
    844
    Market Cap (Aug-2026)
    31.003 Billion USD
    World Rank (Jan-05-2024)
    473
    Market Cap (Jan-05-2024)
    38.171 Billion USD
    World Rank (Jul-30-2023)
    470
    Market Cap (Jul-30-2023)
    38.390 Billion USD
    World Rank (Dec-25-2022)
    405
    Market Cap (Dec-25-2022)
    40.199 Billion USD
    World Rank (Jan-07-2022)
    609
    Market Cap (Jan-07-2022)
    34.17 Billion USD
    Annual Revenue in USD
    10,173 Million USD
    Annual Operating Income in USD
    2,901 Million USD
    Annual Net Income in USD
    3,046 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Biogen INC is USA based Bio-Technology Company and they are pioneers in neuroscience medical science. Headquarters is in Massachusetts, USA.

  8. Fresenius SE

    World Rank (Aug-2026)
    854
    Market Cap (Aug-2026)
    30.655 Billion USD
    World Rank (Jan-05-2024)
    1,002
    Market Cap (Jan-05-2024)
    17.879 Billion USD
    World Rank (Jul-30-2023)
    1,015
    Market Cap (Jul-30-2023)
    17.866 Billion USD
    World Rank (Dec-25-2022)
    1,057
    Market Cap (Dec-25-2022)
    15.656 Billion USD
    World Rank (Jan-07-2022)
    771
    Market Cap (Jan-07-2022)
    27.03 Billion USD
    Annual Revenue in USD
    45,028 Million USD
    Annual Operating Income in USD
    3,662 Million USD
    Annual Net Income in USD
    1,513 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Hospitals and health centers managing and operating company with headquarters is in Germany. Expert in providing dialysis solutions for kidney patients.

  9. Alnylam Pharmaceuticals

    World Rank (Aug-2026)
    855
    Market Cap (Aug-2026)
    30.595 Billion USD
    World Rank (Jan-05-2024)
    763
    Market Cap (Jan-05-2024)
    24.134 Billion USD
    World Rank (Jul-30-2023)
    762
    Market Cap (Jul-30-2023)
    24.817 Billion USD
    World Rank (Dec-25-2022)
    578
    Market Cap (Dec-25-2022)
    29.268 Billion USD
    World Rank (Jan-07-2022)
    1,156
    Market Cap (Jan-07-2022)
    17.72 Billion USD
    Annual Revenue in USD
    1,037 Million USD
    Annual Operating Income in USD
    -785 Million USD
    Annual Net Income in USD
    -1,131 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    ALNYLAM PHARMACEUTICALS is Biopharmaceutical company with headquarters is in Massachusetts, USA.ALNYLAM leaders from the biopharmaceutical industry, bringing together their experiences of drug discovery, drug development, and commercialization.Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines.

  10. Zoetis

    World Rank (Aug-2026)
    858
    Market Cap (Aug-2026)
    30.492 Billion USD
    World Rank (Jan-05-2024)
    168
    Market Cap (Jan-05-2024)
    89.086 Billion USD
    World Rank (Jul-30-2023)
    164
    Market Cap (Jul-30-2023)
    87.755 Billion USD
    World Rank (Dec-25-2022)
    202
    Market Cap (Dec-25-2022)
    67.935 Billion USD
    World Rank (Jan-07-2022)
    156
    Market Cap (Jan-07-2022)
    99.87 Billion USD
    Annual Revenue in USD
    9,467 Million USD
    Annual Operating Income in USD
    3,546 Million USD
    Annual Net Income in USD
    2,673 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Zoetis is a Pharmaceutical company manufacturing medicine and vaccinations for animals. Headquarters is in USA. As on 2021, Zoetis have over 12,100 employees. Zoetis headquarters is in USA.

    As on 2022, Zoetis has 13,800 employees.

    Zoetis annual revenue generated for period ending Dec-2022 was 8,080 million USD.

    Zoetis annual net income generated for period ending Dec-2022 was 2,114 million USD.

Share

Ads